1) A l l e n s p a c h K , C u l v e r w e l l C , C h a n D .
Long-term outcome in dogs with chronic
enteropathies: 203 cases. Vet Rec 178, 368,
2016.
2) Allenspach K, Mochel JP. Current diagnostics
for chronic enteropathies in dogs. Vet Clin
Pathol 50 Suppl 1, 18–28, 2022.
3) Allenspach K, Wieland B, Gröne A, Gaschen F.
Chronic enteropathies in dogs: evaluation of
risk factors for negative outcome. J Vet Intern
Med 21, 700–708, 2007.
4) B o t t e r o E , F e r r i a n i R , B e n v e n u t i E ,
Ruggiero P, Astorina S, Giraldi M, Bertoldi
L, Benvenuto G, Sattin E, Gianella P,
Suchodolski JS. Clinical evaluation and
microbiota analysis in 9 dogs with antibioticresponsive enteropathy: A prospective
comparison study. J Vet Intern Med 36, 1220–
1228, 2022.
5) Cerquetella M, Rossi G, Suchodolski JS,
Schmitz SS, Allenspach K, Rodríguez-Franco
F, Furlanello T, Gavazza A, Marchegiani A,
Unterer S, Burgener IA, Pengo G, Jergens AE.
33
Proposal for rational antibacterial use in the
diagnosis and treatment of dogs with chronic
diarrhoea. J Small Anim Pract 61, 211–215,
2020.
6) Chicheportiche Y, Chicheportiche R, Sizing I,
Thompson J, Benjamin CB, Ambrose C, Dayer
JM. Proinflammatory activity of TWEAK on
human dermal fibroblasts and synoviocytes:
blocking and enhancing effects of antiTWEAK monoclonal antibodies. Arthritis Res
4, 126–133, 2002.
7) Chimura N, Kondo N, Shibata S, Kimura T,
Mori T, Hoshino Y, Murayama N, Nagata M,
Ide K, Nishifuji K, Kamishina H, Maeda S.
Gene transcription analysis in lesional skin
of canine epitheliotropic cutaneous lymphoma
using quantitative real-time RT-PCR. Vet
Immunol Immunopathol 144, 329–336, 2011.
8) Cole AM, Ganz T, Liese AM, Burdick MD, Liu
L, Strieter RM. Cutting edge: IFN-inducible
ELR- CXC chemokines display defensin-like
antimicrobial activity. J Immunol 167, 623–
627, 2001.
9) Dandrieux JRS. Inflammatory bowel disease
versus chronic enteropathy in dogs: are they
one and the same? J Small Anim Pract 57,
589–599, 2016.
10) Dandrieux JRS, Mansfield CS. Chronic
enteropathy in canines: prevalence, impact
and management strategies. Vet Med (Auckl)
10, 203–214, 2019.
11) Di Martino L, Osme A, Kossak-Gupta S,
Pizarro TT, Cominelli F. TWEAK/Fn14 is
overexpressed in Crohn’s disease and mediates
experimental ileitis by regulating critical
innate and adaptive immune pathways. Cell
Mol Gastroenterol Hepatol 8, 427–446, 2019.
12) Dohi T, Borodovsky A, Wu P, Shearstone JR,
Kawashima R, Runkel L, Rajman L, Dong
X, Scott ML, Michaelson JS, Jakubowski
A, Burkly LC. TWEAK/Fn14 pathway: a
nonredundant role in intestinal damage in
mice through a TWEAK/intestinal epithelial
cell axis. Gastroenterology 136, 912–923,
2009.
13) Dohi T, Burkly LC. The TWEAK/Fn14
pathway as an aggravating and perpetuating
34
TWEAK AND FN14 IN CHRONIC ENTEROPATHY
factor in inflammatory diseases: focus on
inflammatory bowel diseases. J Leukoc Biol
92, 265–279, 2012.
14) Eissa N, Kittana H, Gomes-Neto JC, Hussein
H. Mucosal immunity and gut microbiota in
dogs with chronic enteropathy. Res Vet Sci
122, 156–164, 2019.
15) Fernández-Laso V, Sastre C, Méndez-Barbero
N, Egido J, Martín-Ventura JL, GómezGuerrero C, Blanco-Colio LM. TWEAK
blockade decreases atherosclerotic lesion
size and progression through suppression of
STAT1 signaling in diabetic mice. Sci Rep 7,
46679, 2017.
16) Furukawa R, Hara Y, Furuya K, Takahashi
K, Nishimura R, Shingaki T, Osada H, Kondo
H, Ohmori K. Expression of genes encoding
interleukin 15 and its receptor subunits in the
duodenal and colonic mucosae of dogs with
chronic enteropathy. Vet Anim Sci 17, 100256,
2022.
17) F u r u k a w a R , T a k a h a s h i K , H a r a Y ,
Nishimura R, Furuya K, Shingaki T, Osada H,
Kondo H, Ohmori K. Clinical characteristics
of dogs presenting with vomiting as a
gastrointestinal sign of chronic enteropathy.
Vet Anim Sci 17, 100255, 2022.
18) G a o H - X , C a m p b e l l S R , B u r k l y L C ,
Jakubowski A, Jarchum I, Banas B, Saleem
MA, Mathieson PW, Berman JW, Michaelson
JS, Putterman C. TNF-like weak inducer of
apoptosis (TWEAK) induces inflammatory and
proliferative effects in human kidney cells.
Cytokine 46, 24–35, 2009.
19) German AJ, Hall EJ, Day MJ. Chronic
intestinal inflammation and intestinal disease
in dogs. J Vet Intern Med 17, 8–20, 2003.
20) Hirokawa M, Takahashi K, Miyajima M,
Furukawa R, Sugita K, Kondo H, Ohmori K.
Expression of genes encoding inflammasome
sensor subunits in the duodenal and colonic
mucosae of dogs with chronic enteropathy. J
Vet Med Sci 83, 1161–1166, 2021.
21) Kawashima R, Kawamura YI, Oshio T, Son A,
Yamazaki M, Hagiwara T, Okada T, InagakiOhara K, Wu P, Szak S, Kawamura YJ,
Konishi F, Miyake O, Yano H, Saito Y, Burkly
LC, Dohi T. Interleukin-13 damages intestinal
mucosa via TWEAK and Fn14 in mice-a
pathway associated with ulcerative colitis.
Gastroenterology 141, 2119–2129.e8, 2011.
22) Makielski K, Cullen J, O’Connor A, Jergens
AE. Narrative review of therapies for chronic
enteropathies in dogs and cats. J Vet Intern
Med 33, 11–22, 2019.
23) Osada H, Ogawa M, Hasegawa A, Nagai
M, Shirai J, Sasaki K, Shimoda M, Itoh H,
Kondo H, Ohmori, K. Expression of epithelial
cell-derived cytokine genes in the duodenal
and colonic mucosae of dogs with chronic
enteropathy. J Vet Med Sci 79, 393–397, 2017.
24) Washabau RJ, Day MJ, Willard MD, Hall
EJ, Jergens AE, Mansell J, Minami T, Bilzer
TW; WSAVA International Gastrointestinal
Standardization Group. Endoscopic, biopsy,
and histopathologic guidelines for the
evaluation of gastrointestinal inflammation
in companion animals. J Vet Intern Med, 24,
10–26, 2010.
25) Winkles JA. The TWEAK-Fn14 cytokinereceptor axis: discovery, biology and
therapeutic targeting. Nat Rev Drug Discov 7,
411–425, 2008.
26) Zhang J-X, Sang M, Zhao W, Ai H-X, Shui
Y, Li J-F, Song R, Zhang S-Q. Molecular
characterization of the canine cytokine
TWEAK (CD255) and its receptor, Fn14
(CD266). Vet Immunol Immunopathol 137,
172–175, 2010.
...
論文の公開元へ
